Financial News
All News about Horizon Therapeutics
![](https://mms.businesswire.com/media/20220411005582/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://www.investors.com/wp-content/uploads/2017/10/stock-raytheon-Patriot-01-company.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/image_3_18.jpg)
![](https://mms.businesswire.com/media/20220331005584/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2232.jpeg)
![](https://mms.businesswire.com/media/20220324005327/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_4709.jpeg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/roce_image_505.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3682.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2269.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-gdd37bc5d2_1920_14.jpg)
Via Benzinga
![](https://mms.businesswire.com/media/20220228005315/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/biotech3_3.jpg)
![](https://mms.businesswire.com/media/20220223005447/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://mms.businesswire.com/media/20220221005403/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3541.png)
![](https://mms.businesswire.com/media/20220216005515/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://mms.businesswire.com/media/20220216005454/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://mms.businesswire.com/media/20220211005601/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://mms.businesswire.com/media/20220215005414/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://mms.businesswire.com/media/20220210005263/en/1355451/5/Horizon_IO_Logo_Full_Colour_RGB.jpg)
Horizon Therapeutics plc Named Title Partner of the Irish Open
February 10, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220207005152/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_2149.jpeg)
![](https://mms.businesswire.com/media/20220123005095/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/pharma-stocks.jpg)
![](https://mms.businesswire.com/media/20220110005332/en/720702/5/Horizon_Logo_Full-Color_RGB_M01.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.